Acumen Pharmaceuticals Stock Market Value
| ABOS Stock | USD 2.20 0.06 2.65% |
| Symbol | Acumen |
Acumen Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Acumen Pharmaceuticals. If investors know Acumen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Acumen Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.38) | Revenue Per Share 0.033 | Return On Assets (0.21) | Return On Equity (0.33) |
The market value of Acumen Pharmaceuticals is measured differently than its book value, which is the value of Acumen that is recorded on the company's balance sheet. Investors also form their own opinion of Acumen Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Acumen Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Acumen Pharmaceuticals' market value can be influenced by many factors that don't directly affect Acumen Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Acumen Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Acumen Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Acumen Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Acumen Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Acumen Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Acumen Pharmaceuticals.
| 10/29/2024 |
| 11/28/2024 |
If you would invest 0.00 in Acumen Pharmaceuticals on October 29, 2024 and sell it all today you would earn a total of 0.00 from holding Acumen Pharmaceuticals or generate 0.0% return on investment in Acumen Pharmaceuticals over 30 days. Acumen Pharmaceuticals is related to or competes with Terns Pharmaceuticals, X4 Pharmaceuticals, Day One, Hookipa Pharma, Amylyx Pharmaceuticals, Inozyme Pharma, and Mereo BioPharma. Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treat... More
Acumen Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Acumen Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Acumen Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 28.07 | |||
| Value At Risk | (6.78) | |||
| Potential Upside | 7.52 |
Acumen Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Acumen Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Acumen Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Acumen Pharmaceuticals historical prices to predict the future Acumen Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.36) | |||
| Total Risk Alpha | (1.05) | |||
| Treynor Ratio | (1.53) |
Acumen Pharmaceuticals Backtested Returns
Acumen Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.0472, which signifies that the company had a -0.0472% return per unit of risk over the last 3 months. Acumen Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Acumen Pharmaceuticals' Mean Deviation of 3.56, risk adjusted performance of (0.04), and Standard Deviation of 4.75 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.22, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Acumen Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Acumen Pharmaceuticals is expected to be smaller as well. At this point, Acumen Pharmaceuticals has a negative expected return of -0.23%. Please make sure to confirm Acumen Pharmaceuticals' treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Acumen Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.21 |
Weak predictability
Acumen Pharmaceuticals has weak predictability. Overlapping area represents the amount of predictability between Acumen Pharmaceuticals time series from 29th of October 2024 to 13th of November 2024 and 13th of November 2024 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Acumen Pharmaceuticals price movement. The serial correlation of 0.21 indicates that over 21.0% of current Acumen Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.21 | |
| Spearman Rank Test | -0.05 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Acumen Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Acumen Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Acumen Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Acumen Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Acumen Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Acumen Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Acumen Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Acumen Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Acumen Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Acumen Pharmaceuticals Lagged Returns
When evaluating Acumen Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Acumen Pharmaceuticals stock have on its future price. Acumen Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Acumen Pharmaceuticals autocorrelation shows the relationship between Acumen Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Acumen Pharmaceuticals.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Acumen Stock Analysis
When running Acumen Pharmaceuticals' price analysis, check to measure Acumen Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acumen Pharmaceuticals is operating at the current time. Most of Acumen Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acumen Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acumen Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acumen Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.